Articles from Biotech Business (October 1, 2005)

Title	Author	Type	Words
ARIAD GETS ORPHAN DRUG DESIGNATION FOR AP23573.			535
CELERA GENOMICS/SEATTLE GENETICS SELECT CANCER TARGET.			631
FDA APPROVES LIGAND'S AVINZA.			401
FORTICAL NASAL SPRAY FOR OSTEOPOROSIS LAUNCHED.			571
LABOTHERM/PURDUE PHARMA SIGN TRAMADOL PACT.			885